These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Development of cardiomyocyte hypotrophy in rats under prolonged treatment with a low dose of a nitric oxide synthesis inhibitor. de Oliveira CF; Cintra KA; Teixeira SA; De Luca IM; Antunes E; De Nucci G Eur J Pharmacol; 2000 Mar; 391(1-2):121-6. PubMed ID: 10720643 [TBL] [Abstract][Full Text] [Related]
25. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Numaguchi K; Egashira K; Takemoto M; Kadokami T; Shimokawa H; Sueishi K; Takeshita A Hypertension; 1995 Dec; 26(6 Pt 1):957-62. PubMed ID: 7490155 [TBL] [Abstract][Full Text] [Related]
26. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Sarr M; Chataigneau M; Martins S; Schott C; El Bedoui J; Oak MH; Muller B; Chataigneau T; Schini-Kerth VB Cardiovasc Res; 2006 Sep; 71(4):794-802. PubMed ID: 16822492 [TBL] [Abstract][Full Text] [Related]
27. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192 [TBL] [Abstract][Full Text] [Related]
28. Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Martin S; Andriambeloson E; Takeda K; Andriantsitohaina R Br J Pharmacol; 2002 Mar; 135(6):1579-87. PubMed ID: 11906973 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin II induces the vascular expression of VEGF and MMP-2 in vivo: preventive effect of red wine polyphenols. Walter A; Etienne-Selloum N; Sarr M; Kane MO; Beretz A; Schini-Kerth VB J Vasc Res; 2008; 45(5):386-94. PubMed ID: 18354258 [TBL] [Abstract][Full Text] [Related]
30. Relaxation induced by red wine polyphenolic compounds in rat pulmonary arteries: lack of inhibition by NO-synthase inhibitor. Leblais V; Krisa S; Valls J; Courtois A; Abdelouhab S; Vila AM; Mérillon JM; Muller B Fundam Clin Pharmacol; 2008 Feb; 22(1):25-35. PubMed ID: 18251719 [TBL] [Abstract][Full Text] [Related]
31. Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy. Rossi MA; Ramos SG; Prado CM J Hypertens; 2003 May; 21(5):993-1001. PubMed ID: 12714875 [TBL] [Abstract][Full Text] [Related]
32. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation? Kopincova J; Puzserova A; Bernatova I Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608 [TBL] [Abstract][Full Text] [Related]
33. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses. López RM; Pérez T; Castillo C; Castillo MC; Castillo EF Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990 [TBL] [Abstract][Full Text] [Related]
34. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats. Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946 [TBL] [Abstract][Full Text] [Related]
35. Nebivolol alleviates aortic remodeling through eNOS upregulation and inhibition of oxidative stress in l-NAME-induced hypertensive rats. Wang Y; Zhang F; Liu Y; Yin S; Pang X; Li Z; Wei Z Clin Exp Hypertens; 2017; 39(7):628-639. PubMed ID: 28640644 [TBL] [Abstract][Full Text] [Related]
36. Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. Chalopin M; Tesse A; Martínez MC; Rognan D; Arnal JF; Andriantsitohaina R PLoS One; 2010 Jan; 5(1):e8554. PubMed ID: 20049322 [TBL] [Abstract][Full Text] [Related]
37. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Bernátová I; Pechánová O; Pelouch V; Simko F J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795 [TBL] [Abstract][Full Text] [Related]
38. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Kaikita K; Fogo AB; Ma L; Schoenhard JA; Brown NJ; Vaughan DE Circulation; 2001 Aug; 104(7):839-44. PubMed ID: 11502712 [TBL] [Abstract][Full Text] [Related]
39. Role of nitric oxide in vascular hyper-responsiveness to norepinephrine in hypertensive Dahl rats. Nishida Y; Ding J; Zhou MS; Chen QH; Murakami H; Wu XZ; Kosaka H J Hypertens; 1998 Nov; 16(11):1611-8. PubMed ID: 9856361 [TBL] [Abstract][Full Text] [Related]